PlainRecalls
FDA Drug Moderate Class II Terminated

Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30

Reported: August 15, 2012 Initiated: May 18, 2012 #D-1442-2012

Product Description

Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30

Reason for Recall

Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.

Details

Units Affected
6,647 cartons
Distribution
Nationwide
Location
Sellersville, PA

Frequently Asked Questions

What product was recalled?
Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 6,647 cartons.
Why was this product recalled?
Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 15, 2012. Severity: Moderate. Recall number: D-1442-2012.